Neuroimaging in psychiatry has faced challenges in demonstrating clinical relevance due to failed replications and lack of definitive evidence. However, new approaches like ultra-high field (UHF) MRI offer improved sensitivity and specificity for individual patient assessments. UHF MRI provides higher signal-to-noise and contrast-to-noise ratios, enhancing the reliability and efficiency of functional MRI. It allows for more precise mapping of brain structures and functions, aiding in understanding neurometabolic processes and brain circuitry. UHF MRI also supports brain stimulation interventions by enabling targeted imaging and measuring changes in brain circuit communication. Studies using UHF MRI have shown structural changes in brain regions linked to psychiatric conditions, such as reduced structural integrity in the ventral tegmental area in anxiety and depression. UHF MRI also reveals mood-related neurocircuit disturbances in major depression not detected with 3T MRI. These findings highlight the potential of UHF MRI in identifying neurometabolic targets, such as glutamate and glutathione, which are relevant to psychiatric conditions. Brain stimulation, particularly deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), can be enhanced with neuroimaging to target specific brain regions and networks. UHF MRI and neuroimaging techniques like 1H MRS and CEST provide detailed insights into brain function and metabolism, supporting the development of personalized treatments. These methods can help identify individual differences in brain responses to treatment and improve the accuracy of treatment prediction. Concurrent imaging with brain stimulation, such as interleaved TMS/fMRI, allows for real-time assessment of circuit engagement and modulation. This approach helps in understanding how stimulation affects brain circuits and can guide the selection of optimal treatment targets. The integration of neuroimaging with brain stimulation interventions is crucial for advancing personalized psychiatry and improving clinical outcomes. Future directions include establishing UHF consortia with standardized guidelines, expanding access to 7T MRI, and refining methods for individualized treatment planning. These efforts aim to enhance the clinical relevance of neuroimaging in psychiatry, ensuring that imaging data can be effectively used to inform and improve patient care.Neuroimaging in psychiatry has faced challenges in demonstrating clinical relevance due to failed replications and lack of definitive evidence. However, new approaches like ultra-high field (UHF) MRI offer improved sensitivity and specificity for individual patient assessments. UHF MRI provides higher signal-to-noise and contrast-to-noise ratios, enhancing the reliability and efficiency of functional MRI. It allows for more precise mapping of brain structures and functions, aiding in understanding neurometabolic processes and brain circuitry. UHF MRI also supports brain stimulation interventions by enabling targeted imaging and measuring changes in brain circuit communication. Studies using UHF MRI have shown structural changes in brain regions linked to psychiatric conditions, such as reduced structural integrity in the ventral tegmental area in anxiety and depression. UHF MRI also reveals mood-related neurocircuit disturbances in major depression not detected with 3T MRI. These findings highlight the potential of UHF MRI in identifying neurometabolic targets, such as glutamate and glutathione, which are relevant to psychiatric conditions. Brain stimulation, particularly deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS), can be enhanced with neuroimaging to target specific brain regions and networks. UHF MRI and neuroimaging techniques like 1H MRS and CEST provide detailed insights into brain function and metabolism, supporting the development of personalized treatments. These methods can help identify individual differences in brain responses to treatment and improve the accuracy of treatment prediction. Concurrent imaging with brain stimulation, such as interleaved TMS/fMRI, allows for real-time assessment of circuit engagement and modulation. This approach helps in understanding how stimulation affects brain circuits and can guide the selection of optimal treatment targets. The integration of neuroimaging with brain stimulation interventions is crucial for advancing personalized psychiatry and improving clinical outcomes. Future directions include establishing UHF consortia with standardized guidelines, expanding access to 7T MRI, and refining methods for individualized treatment planning. These efforts aim to enhance the clinical relevance of neuroimaging in psychiatry, ensuring that imaging data can be effectively used to inform and improve patient care.